We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation.
- Authors
Bai, Xuemei; Sui, Chao; Liu, Feng; Chen, Tian; Zhang, Lei; Zheng, Yi; Liu, Bingyu; Gao, Chengjiang
- Abstract
The signaling adaptor MAVS forms prion-like aggregates to activate the innate antiviral immune response after viral infection. However, spontaneous aggregation of MAVS can lead to autoimmune diseases. The molecular mechanism that prevents MAVS from spontaneous aggregation in resting cells has been enigmatic. Here we report that protein arginine methyltransferase 9 targets MAVS directly and catalyzes the arginine methylation of MAVS at the Arg41 and Arg43. In the resting state, this modification inhibits MAVS aggregation and autoactivation of MAVS. Upon virus infection, PRMT9 dissociates from the mitochondria, leading to the aggregation and activation of MAVS. Our study implicates a form of post-translational modification on MAVS, which can keep MAVS inactive in physiological conditions to maintain innate immune homeostasis. The anti-viral protein MAVS forms aggregates as part of the antiviral response and promoting type I IFN responses. Here the authors show that protein arginine methyltransferase 9 (PRMT9) methylates MAVS to keep the protein in a non-aggregated state and propose a regulatory mechanism for MAVS.
- Subjects
PROTEIN arginine methyltransferases; ARGININE; CELL aggregation; POST-translational modification; METHYLATION; METHYLTRANSFERASES; PRIONS; VIRUS diseases
- Publication
Nature Communications, 2022, Vol 13, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-022-32628-y